Wealth Enhancement Trust Services’s Inspire Medical Systems INSP Stock Holding History

Wealth Enhancement Trust Services’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$580	Buy	+13	New	+$617	﹤0.01%	1221

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wealth Enhancement Trust Services's INSP Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 13 shares worth $580. The stake represents ﹤0.01% of the portfolio and ranks #1221 among its holdings.

160 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Wealth Enhancement Trust Services held 13 shares of Inspire Medical Systems worth $580 as of Q2 2026.
Inspire Medical Systems was a new Wealth Enhancement Trust Services position in Q2 2026.
Inspire Medical Systems made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1221 holding.
160 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.